(Date:12/2/2009)...ntists may not be able to tell a good book by its ...ld book by its smell. In a report in ACS, Analyti...ibe development of a new test that can measure the...documents based on their smell. The nondestructive...serve a range of prized paper-based objects, some ...
(Date:12/2/2009)...ampions Biotechnology, Inc. (OTC Bulletin Board: C...h a predictive preclinical platform aimed at accel... oncology drugs, has established an exclusive lice...Ltd., Tel Aviv University,s wholly owned technolog...ncompasses the development and commercialization o...
(Date:12/2/2009)... MyCareTeam, Inc., a leading vend...ftware, has released the newest version of its sof...rtension, congestive heart failure and weight mana...abetes monitoring features. , ...reTeam, Inc., a leading vendor of Internet-based c...
(Date:12/2/2009)... , ARLINGTON, Va., Dec. 2 Fro...life that give us meaning, joy and peace, the LIFE...ever contest conducted using the popular photo-sha...e viewed in a video montage on the LIFE Foundation.... ,, Contestants submitted one photo and a cap...
(Date:12/2/2009)... , MORRISTOWN, N.J., Dec. 2 /PRNewswire-FirstCa... today announced that the Federal Trade Commission...ublic comment relating to Watson,s pending acquisi... early termination of the Hart Scott Rodino waitin...the transaction. The parties have now obtained al...
Breaking Medicine News(10 mins):Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2... pill that could give a longer lease of life to pa... when given along with chemotherapy drugs.
Pa... Novacea lived for an average of an extra nine mon...f the vitamin without running the risk of side eff...
...cial transplantation—including the psychological a...e—a Working Party of the Royal College of Surgeons... in performing further face transplants, according...tation should not be attempted until further resea...
...vard School of Public Health (HSPH) finds that pol... in a net savings of over $180 billion, even witho...ated with avoided fear and suffering. This first s...of Risk Analysis.
The history of polio vaccin...
... and gamblers in Britain. A study reveals// that E...inos then on vegetables and fruits.
On an ave...ambling in United Kingdom. Online gambling has als...enagers getting addicted to this habit. An analysi...
...eans high pressure in the arteries. High blood pre...iller’ because one can have it for years without k...P when his blood pressure reading is around 120/80...
Approx. 2.5 million Canadians have high-norm...
...e of the largest eye care hospital networks in sou...ith seven more in the offing.
The Chennai fa...emraj, a prominent ophthalmic surgeon and managing...t for the eight hospitals. Fifty percent of the fu...
Other Medicine News:Health News:Royal College Issues Revised Guidelines for Face Transplantation 2Health News:Royal College Issues Revised Guidelines for Face Transplantation 3Health News:Billions of Dollars Saved in U.S. By Polio Vaccination 2Health News:Slightly High Blood Pressure is Also Hazardous 2...o be Presented at Lymphoma Meeting in Lugano, Swit...el,today reported an abstract providing preliminar...Syk inhibitor, R788 (fostamatinib disodium), in,pa...kin,s lymphomas (NHL).,The abstract reports favora...mphocytic lymphoma/chronic lymphocytic leukemia (S...
... FRANCISCO, Calif., June 2 Rigel,Pharmaceuticals,...l host a,conference call with simultaneous webcast... clinical study of R788, a novel, oral Syk kinase,...ymphomas on Tuesday, June,3, 2008 at 8:00 a.m. EDT...anagement and the principal investigator on the st...
Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: